Croda International Future Growth

Future criteria checks 3/6

Croda International is forecast to grow earnings and revenue by 16.5% and 4.8% per annum respectively. EPS is expected to grow by 16.3% per annum. Return on equity is forecast to be 9.4% in 3 years.

Key information

16.5%

Earnings growth rate

16.30%

EPS growth rate

Chemicals earnings growth	9.2%
Revenue growth rate	4.8%
Future return on equity	9.36%
Analyst coverage	Good
Last updated	20 Oct 2025

Recent future growth updates

Recent updates

Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around

Oct 06

Croda International Plc's (LON:CRDA) P/E Is On The Mark

Sep 18

Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly

Aug 15

Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 35% Above Its Share Price

Jul 12

Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly

May 08

What Croda International Plc's (LON:CRDA) P/E Is Not Telling You

Apr 11

Is There An Opportunity With Croda International Plc's (LON:CRDA) 24% Undervaluation?

Mar 30

Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook

Mar 02 Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.

Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around

Feb 18

Croda International (LON:CRDA) Has A Somewhat Strained Balance Sheet

Dec 10

Earnings Tell The Story For Croda International Plc (LON:CRDA)

Oct 29

Earnings and Revenue Growth Forecasts

LSE:CRDA - Analysts future estimates and past financials data (GBP Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2027	1,848	220	215	324	11
12/31/2026	1,753	192	171	289	12
12/31/2025	1,682	159	130	257	12
6/30/2025	1,668	140	72	221	N/A
3/31/2025	1,648	149	105	270	N/A
12/31/2024	1,628	159	138	319	N/A
9/30/2024	1,629	161	163	354	N/A
6/30/2024	1,630	163	189	388	N/A
3/31/2024	1,662	167	169	363	N/A
12/31/2023	1,695	171	149	338	N/A
9/30/2023	1,769	182	172	355	N/A
6/30/2023	1,843	194	196	373	N/A
3/31/2023	1,966	422	176	340	N/A
12/31/2022	2,089	649	156	308	N/A
9/30/2022	2,086	680	151	297	N/A
6/30/2022	2,083	711	145	286	N/A
3/31/2022	1,986	516	167	317	N/A
12/31/2021	1,890	321	189	348	N/A
9/30/2021	1,771	284	166	322	N/A
6/30/2021	1,651	247	144	296	N/A
3/31/2021	1,521	224	155	291	N/A
12/31/2020	1,390	202	166	287	N/A
9/30/2020	1,363	204	N/A	N/A	N/A
6/30/2020	1,336	207	181	299	N/A
3/31/2020	1,357	216	187	301	N/A
12/31/2019	1,378	224	193	304	N/A
9/30/2019	1,388	230	N/A	N/A	N/A
6/30/2019	1,399	235	185	278	N/A
3/31/2019	1,393	237	N/A	270	N/A
12/31/2018	1,387	239	N/A	262	N/A
9/30/2018	1,378	241	N/A	265	N/A
6/30/2018	1,369	244	N/A	269	N/A
3/31/2018	1,371	241	N/A	266	N/A
12/31/2017	1,373	237	N/A	263	N/A
9/30/2017	1,358	226	N/A	267	N/A
6/30/2017	1,342	214	N/A	272	N/A
3/31/2017	1,293	206	N/A	268	N/A
12/31/2016	1,244	197	N/A	264	N/A
9/30/2016	1,185	192	N/A	247	N/A
6/30/2016	1,126	187	N/A	230	N/A
3/31/2016	1,104	184	N/A	219	N/A
12/31/2015	1,082	181	N/A	208	N/A
9/30/2015	1,078	178	N/A	201	N/A
6/30/2015	1,074	175	N/A	194	N/A
3/31/2015	1,060	170	N/A	184	N/A
12/31/2014	1,047	165	N/A	175	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRDA's forecast earnings growth (16.5% per year) is above the savings rate (2.7%).

Earnings vs Market: CRDA's earnings (16.5% per year) are forecast to grow faster than the UK market (14.4% per year).

High Growth Earnings: CRDA's earnings are forecast to grow, but not significantly.

Revenue vs Market: CRDA's revenue (4.8% per year) is forecast to grow faster than the UK market (4.2% per year).

High Growth Revenue: CRDA's revenue (4.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CRDA's Return on Equity is forecast to be low in 3 years time (9.4%).

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/22 17:30
End of Day Share Price	2025/10/22 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Croda International Plc is covered by 35 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Robert Bate	Barclays
James Knight	Barclays
James Stewart	Barclays

Croda International Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 10%

Price target decreased by 7.7% to UK£70.33

Recent updates

Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025

Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around

Croda International Plc's (LON:CRDA) P/E Is On The Mark

Upcoming dividend of UK£0.48 per share

Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly

First half dividend increased to UK£0.48

Croda International plc Announces an Interim Dividend in Respect of 2025, Payable on 7 October 2025

First half 2025 earnings released: EPS: UK£0.44 (vs UK£0.57 in 1H 2024)

Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 35% Above Its Share Price

Now 22% undervalued

Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly

What Croda International Plc's (LON:CRDA) P/E Is Not Telling You

Upcoming dividend of UK£0.63 per share

Is There An Opportunity With Croda International Plc's (LON:CRDA) 24% Undervaluation?

Now 21% undervalued after recent price drop

Less than half of directors are independent

Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025

Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook

Final dividend increased to UK£0.63

New major risk - Dividend sustainability

Full year 2024 earnings: EPS misses analyst expectations

Croda International Plc, Annual General Meeting, Apr 23, 2025

Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2024, Payable on May 28, 2025

Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around

Croda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026

Now 21% overvalued

Croda International (LON:CRDA) Has A Somewhat Strained Balance Sheet

Croda International plc Announces Directorate Change

Earnings Tell The Story For Croda International Plc (LON:CRDA)

First half dividend of UK£0.47 announced

First half 2024 earnings released: EPS: UK£0.57 (vs UK£0.63 in 1H 2023)

Stephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025

High number of new directors

Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees

Croda International Plc Declares Final Dividend

Upcoming dividend of UK£0.62 per share

Consensus EPS estimates fall by 11%

Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024

Final dividend increased to UK£0.62

Full year 2023 earnings: EPS misses analyst expectations

Now 21% overvalued after recent price rise

Less than half of directors are independent

Croda International Plc to Report First Half, 2024 Results on Jul 30, 2024

Now 24% overvalued after recent price rise

Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024

Croda International plc Announces Resignation of Louisa Burdett from Board

Consensus EPS estimates fall by 11%

Group Chief Scientific Officer recently sold UK£20m worth of stock

Croda International Plc, Annual General Meeting, Apr 24, 2024

Upcoming dividend of UK£0.47 per share at 2.0% yield

New minor risk - Profit margin trend

First half 2023 earnings released: EPS: UK£0.63 (vs UK£3.90 in 1H 2022)

Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370).

Consensus EPS estimates fall by 10%

Price target decreased by 7.7% to UK£70.33

Investor sentiment deteriorates as stock falls 15%

Key Executive exercised options and sold UK£1.0m worth of stock

President of Corporate Development recently sold UK£210k worth of stock

Upcoming dividend of UK£0.61 per share at 1.5% yield

President of Regional Delivery exercised options and sold UK£232k worth of stock

Executive Director recently sold UK£486k worth of stock

President of Regional Delivery recently sold UK£580k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion.

Independent Non-Executive Director recently bought UK£54k worth of stock

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies